Biomarkers to Predict Time to Plasma HIV RNA Rebound

Completed

Conditions studied: HIV-1 Infection

In brief

The purpose of this study is to collect information about what happens when people pause, or temporarily stop taking, ART, and to collect blood samples from these people at frequent intervals. We will also study the safety of pausing ART under close observation.

Key facts

Study ID
NCT03001128
Run by
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
People needed
61
Starts
2017-02-23
Expected to finish
2021-01-29
Last updated by the study team
2024-12-13

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.